Participated · Seed · Sep 2025

SuperFam is a comprehensive, privacy-first app built to streamline modern family life by consolidating household finances, location tracking, safety features, and critical family information within a single, encrypted platform. Founded in 2024 by Jozzire Lyngdoh and Mohit Agrawal, the product stores data on-device with end-to-end encryption, positioning itself as a secure bridge between general productivity tools and family-specific needs. The company plans to augment its core offering with an AI co-pilot that uses contextual data to simplify everyday decisions without compromising privacy. Since its launch in March 2025, SuperFam has attracted more than 30,000 active users across Android and iOS, demonstrating strong engagement and retention. The service is currently free to use. Over the next 12–18 months, management aims to serve 10 million families and enter strategic partnerships to extend the product’s reach.

Participated · Equity · Jul 2025

Opennote is an interactive AI learning ecosystem that enables students to personalize and engage with their course content. The platform lets users consolidate class materials and transform them into AI-generated videos, diagrams, and workflows. Founded in 2016 and headquartered in San Francisco, Opennote currently serves users in nearly 100 countries and maintains a campus ambassador program across top North American institutions. In April 2025 the company raised $850,000 in an all-equity round. Opennote will use the funds to support international expansion, scale operations beyond California’s Bay Area, and hire technical talent. The product is positioned in EdTech as an AI-powered personalization platform aimed at improving student engagement with course material.

Participated · Series A · Dec 2024

Abselion develops automated analytical instrumentation, notably its Amperia benchtop system, to simplify at-line protein analytics for biologics development and production. The company’s RED (redox-electrochemical-detection) technology enables sensitive, specific measurement of antibodies, AAVs and other proteins directly from crude samples, producing results in as little as one minute. Abselion positions the Amperia to deliver on-the-spot process insights that improve efficiency and accuracy in life‑science research and bioprocessing. The product targets applications across development and production workflows for biologics such as antibodies and viral vectors. The company is led by CEO Ruizhi Wang and is based in Cambridge, UK. Recent fundraising is intended to support commercialisation and to expand the Amperia system’s capabilities. HexagonFab is a University of Cambridge spin-out that develops affordable, convenient analytical lab instruments to simplify biomolecular interaction analysis for pharma research and manufacturing. Its first product, the Bolt, is a handheld device that uses electrical detection with a graphene-based semiconductor sensor to measure protein, antibody and small-molecule affinity and kinetics down to low nanomolar concentrations. The Bolt provides real-time signals, requires no installation, and delivers results in hours rather than days, enabling on-site testing by researchers and manufacturing quality-control teams. HexagonFab positions the Bolt to reduce costs, delays and failures in biopharmaceutical discovery and production, accelerating development of novel medicines for small patient populations. Proceeds from the seed round will be used to grow the team, complete development of the Bolt, and launch the product commercially. The company describes its instruments as convenient, accessible and affordable for scientists, researchers, and drug manufacturers.

Participated · Seed · Feb 2024

CarePay operates a fintech platform focused on creating a financially inclusive healthcare ecosystem via a B2B2C model that provides patients immediate capital to access care. The company recorded $10 million in annualised transactions and achieved 100% month-on-month growth in 2023. It plans to onboard 10,000 healthcare centres by FY24 and expects 50%–70% month-on-month growth in the current quarter. CarePay raised $850K in pre-seed capital in August 2023 to accelerate scale. Leadership, including Co‑Founder and CEO Gaurav Gupta, says the firm aims for a 20x increase in scale and to reach profitability by the end of the year. The funds are being used to expand the platform’s reach and deepen its partnerships with healthcare providers.

Participated · Seed · Feb 2024

Segwise is developing AI agents that operate across the mobile product growth stack, from observing data to identifying problems and opportunities to running growth experiments. The platform fine-tunes AI models for tasks specific to mobile product growth and enables deep integrations across multiple data sources and tools. Founders Brijesh Bharadwaj and Shobhit Gupta lead the product and technical vision. The company is positioning its agents to support product and growth teams at multiple stages of the funnel. Segwise recently completed a $1.6 million pre-seed financing to support product development and go-to-market efforts. The business emphasizes integrations and model customization for the mobile growth universe.